# عنوان نوع فایل سایز فایل بازدید دانلود امتیاز قیمت (تومان)
1
Combination HIV Prevention: Significance, Challenges, and Opportunities
702.00 KB 69 0
رایگان
2
Pathogenesis of HIV in the Central Nervous System
249.88 KB 98 0
رایگان
3
Coreceptors and HIV-1 Pathogenesis
298.94 KB 177 0
رایگان
4
Point-of-Care Testing
167.55 KB 72 0
رایگان
5
Alterations of the B-Cell Response by HIV-1 Replication
327.64 KB 67 0
رایگان
6
Revisiting Immune Exhaustion During HIV Infection
172.63 KB 83 0
رایگان
7
IL28B Polymorphisms and Treatment of Hepatitis C
226.20 KB 69 0
رایگان
8
Rational Guide to the Use of Erythropoietin in the Treatment of HCV Infection
195.84 KB 499 0
رایگان
9
Management of Hepatitis C Antiviral Therapy Adverse Effects
165.48 KB 78 1
رایگان
10
HCV Eradication: Implications for Disease Resolution
144.31 KB 60 0
رایگان
11
Update on Current Epidemiologic Trends in Hepatitis C
157.69 KB 67 0
رایگان
12
Extrahepatic Manifestations of Hepatitis C Virus Infection: Mixed Cryoglobulinemia and Beyond
152.91 KB 64 0
رایگان
13
HCV Response-Guided Therapy: Should Treatment Length Be Shortened or Extended?
154.25 KB 62 0
رایگان
14
The Emerging Role of Histone Deacetylase Inhibitors in Treating T-cell Lymphomas
123.41 KB 80 0
رایگان
15
Burkitt Lymphoma and Atypical Burkitt or Burkitt-like Lymphoma: Should These be Treated as Different Diseases?
166.96 KB 70 0
رایگان
16
The Role of Transplantation in Diffuse Large B-Cell Lymphoma: The Impact of Rituximab Plus Chemotherapy in First-line and Relapsed Settings
208.01 KB 147 0
رایگان
17
New Immunomodulatory Drugs in Myeloma
136.76 KB 67 0
رایگان
18
Special Issues in Myeloproliferative Neoplasms
155.10 KB 62 0
رایگان
19
Future Therapies for the Myeloproliferative Neoplasms
127.22 KB 73 0
رایگان
20
The Search for Better Prognostic Models in Myelodysplastic Syndromes
177.92 KB 70 0
رایگان
21
Therapeutic Modalities for Patients with Lower-Risk Myelodysplastic Syndromes: Current Options and Future Directions
200.22 KB 67 0
رایگان
22
Recognition and Management of Sleep-Disordered Breathing in Chronic Heart Failure
284.16 KB 72 0
رایگان
23
Controversies in Cardiac Resynchronization Therapy: Do Sex Differences in Response Exist?
127.31 KB 64 0
رایگان
24
Mechanical Bridge to Decision: What Are the Options for the Management of Acute Refractory Cardiogenic Shock?
241.11 KB 149 0
رایگان
25
Targeting Hyponatremia and Hemodynamics in Acute, Decompensated Heart Failure: Is There a Role for Vasopressin Antagonists?
231.00 KB 61 0
رایگان
Combination HIV Prevention: Significance, Challenges, and Opportunities

Combination HIV Prevention: Sig ...

No single HIV prevention strategy will be sufficient to control the HIV pandemic. However, a growing number of interventions have shown promise in p ...

702.00 KB
رایگان
Pathogenesis of HIV in the Central Nervous System

Pathogenesis of HIV in the Cent ...

HIV can infect the brain and impair central nervous system (CNS) function. Combination antiretroviral therapy (cART) has not eradicated CNS complica ...

249.88 KB
رایگان
Coreceptors and HIV-1 Pathogenesis

Coreceptors and HIV-1 Pathogene ...

The major HIV-1 coreceptors, CCR5 and CXCR4, mediate virus entry into CD4+ cells and are therefore a critical component of the HIV-1 life cycle. Al ...

298.94 KB
رایگان
Point-of-Care Testing

Point-of-Care Testing

The availability of rapid, point-of-care (POC) tests has significantly expanded the capacity of both developed and resource-constrained countries (R ...

167.55 KB
رایگان
Alterations of the B-Cell Response by HIV-1 Replication

Alterations of the B-Cell Respo ...

While the hallmark of HIV-1 infection is the progressive depletion of CD4+ T cells, extensive B-cell dysfunction ensues that impairs the quality of ...

327.64 KB
رایگان
Revisiting Immune Exhaustion During HIV Infection

Revisiting Immune Exhaustion Du ...

Chronic immune activation is a hallmark of HIV infection, yet the underlying triggers of immune activation remain unclear. Persistent antigenic stim ...

172.63 KB
رایگان
IL28B Polymorphisms and Treatment of Hepatitis C

IL28B Polymorphisms and Treatme ...

Recently, single-nucleotide polymorphisms near the IL28B gene have been identified as important in predicting treatment response and spontaneous cle ...

226.20 KB
رایگان
Rational Guide to the Use of Erythropoietin in the Treatment of HCV Infection

Rational Guide to the Use of Er ...

Hepatitis C virus (HCV) infection is the leading reason for liver transplant in North America. Combination therapy with pegylated interferon and ri ...

195.84 KB
رایگان
Management of Hepatitis C Antiviral Therapy Adverse Effects

Management of Hepatitis C Antiv ...

Hepatitis C is one of the leading causes of liver disease in the United States, affecting more than 4 million individuals. The current treatment reg ...

دانلود 1
165.48 KB
رایگان
HCV Eradication: Implications for Disease Resolution

HCV Eradication: Implications f ...

Hepatitis C virus (HCV) is a leading cause of liver-related death worldwide. The evolution of hepatitis C therapy has made serologic eradication of ...

144.31 KB
رایگان
Update on Current Epidemiologic Trends in Hepatitis C

Update on Current Epidemiologic ...

Hepatitis C virus infection remains a leading cause of liver disease worldwide and is currently the principal reason for liver transplantation in th ...

157.69 KB
رایگان
Extrahepatic Manifestations of Hepatitis C Virus Infection: Mixed Cryoglobulinemia and Beyond

Extrahepatic Manifestations of ...

Hepatitis C virus (HCV) is the most common blood-borne infection in the United States and is a leading cause of chronic liver disease worldwide. Ext ...

152.91 KB
رایگان
HCV Response-Guided Therapy: Should Treatment Length Be Shortened or Extended?

HCV Response-Guided Therapy: Sh ...

The treatment of chronic HCV has traditionally been for a fixed duration based on genotype. We now recognize that patients respond to treatment alon ...

154.25 KB
رایگان
The Emerging Role of Histone Deacetylase Inhibitors in Treating T-cell Lymphomas

The Emerging Role of Histone De ...

T-cell lymphomas are an uncommon and heterogeneous group of non-Hodgkin lymphomas. Historically, therapies for these diseases have been borrowed fro ...

123.41 KB
رایگان
Burkitt Lymphoma and Atypical Burkitt or Burkitt-like Lymphoma: Should These be Treated as Different Diseases?

Burkitt Lymphoma and Atypical B ...

Burkitt lymphoma (BL) is a mature B-cell non- Hodgkin lymphoma with an aggressive clinical course. Since the advent of short, intensive, multiagent ...

166.96 KB
رایگان
The Role of Transplantation in Diffuse Large B-Cell Lymphoma: The Impact of Rituximab Plus Chemotherapy in First-line and Relapsed Settings

The Role of Transplantation in ...

Rituximab has improved the prognosis of patients with diffuse large B-cell lymphoma, but a high proportion of patients with advanced disease will re ...

208.01 KB
رایگان
New Immunomodulatory Drugs in Myeloma

New Immunomodulatory Drugs in M ...

Multiple myeloma (MM) is an incurable malignancy of plasma cells. The introduction of thalidomide was a milestone in the treatment of MM. Thalidomid ...

136.76 KB
رایگان
Special Issues in Myeloproliferative Neoplasms

Special Issues in Myeloprolifer ...

Special issues in myeloproliferative neoplasms (MPN) comprise clinical conditions with high relevance for the duration and quality of the patient’s ...

155.10 KB
رایگان
Future Therapies for the Myeloproliferative Neoplasms

Future Therapies for the Myelop ...

Ever since their description as “myeloproliferative syndromes” by William Dameshek in 1951, the myeloproliferative neoplasms (MPNs) have been manage ...

127.22 KB
رایگان
The Search for Better Prognostic Models in Myelodysplastic Syndromes

The Search for Better Prognosti ...

Myelodysplastic syndromes (MDS) are a group of heterogeneous bone marrow disorders characterized by a failure of hematopoiesis and an increased prop ...

177.92 KB
رایگان
Therapeutic Modalities for Patients with Lower-Risk Myelodysplastic Syndromes: Current Options  and Future Directions

Therapeutic Modalities for Pati ...

The treatment of myelodysplastic syndromes (MDS) involves a complex algorithm that depends on multiple factors, including symptoms, performance stat ...

200.22 KB
رایگان
Recognition and Management of Sleep-Disordered Breathing in Chronic Heart Failure

Recognition and Management of S ...

It is increasingly recognized that sleep-disordered breathing (SDB) is a common modifiable risk factor for cardiovascular disease with significant i ...

284.16 KB
رایگان
Controversies in Cardiac Resynchronization Therapy: Do Sex Differences in Response Exist?

Controversies in Cardiac Resync ...

Cardiac resynchronization therapy (CRT) is well established in the treatment of patients with heart failure, but lacks data addressing sex differenc ...

127.31 KB
رایگان
Mechanical Bridge to Decision: What Are the Options for the Management of Acute Refractory Cardiogenic Shock?

Mechanical Bridge to Decision: ...

While great strides have been made in the management of heart failure syndromes, acute refractory cardiogenic shock carries a dismal prognosis. Init ...

241.11 KB
رایگان
Targeting Hyponatremia and Hemodynamics in Acute, Decompensated Heart Failure: Is There a Role for Vasopressin Antagonists?

Targeting Hyponatremia and Hemo ...

Current treatment of acute decompensated heart failure (ADHF) has not reduced the significant morbidity or mortality associated with this disease, a ...

231.00 KB
رایگان

بارگزاری